Application of a prediction model with laboratory indexes in the risk stratification of patients with COVID-19

Jiru Ye1, Xiaoqing Zhang2, Feng Zhu2

  • 1Department of Respiratory and Critical Care Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu 213003, P.R. China.

Insights

A new prediction model combining laboratory indexes effectively stratifies COVID-19 patients by severity. This model, using red blood cell count, high-sensitivity C-reactive protein (hsCRP), and procalcitonin (PCT), shows promise for clinical risk assessment.

Area of Science:

  • Clinical Medicine
  • Infectious Diseases
  • Biomarkers

Background:

  • Accurate risk stratification is crucial for managing Coronavirus Disease 2019 (COVID-19) patients.
  • Identifying reliable laboratory predictors for COVID-19 severity is essential for timely clinical intervention.

Purpose of the Study:

  • To establish and validate a prediction model using combined laboratory indexes for COVID-19 patient risk stratification.
  • To compare the diagnostic efficacy and clinical utility of individual laboratory markers and the developed prediction model.

Main Methods:

  • Retrospective analysis of 170 COVID-19 patients, categorized into asymptomatic-moderate and severe or above groups.
  • Multivariate logistic regression was employed to construct a prediction model based on significant laboratory indexes.
  • Receiver operating characteristic (ROC) curve and Decision Curve Analysis (DCA) were used to evaluate diagnostic performance and clinical validity.

Main Results:

  • Significant differences in blood cell count, high-sensitivity C-reactive protein (hsCRP), and procalcitonin (PCT) were observed between severity groups (P<0.05).
  • Individual hsCRP demonstrated high diagnostic efficacy (AUC=0.870).
  • The combined prediction model (red blood cell count, hsCRP, PCT) showed a higher AUC (0.912) and superior net benefit in DCA compared to individual markers.

Conclusions:

  • A prediction model integrating red blood cell count, hsCRP, and PCT effectively predicts clinical classification in COVID-19 patients.
  • This model offers improved clinical utility for risk stratification compared to individual laboratory indexes.
  • The developed model serves as a valuable tool for assessing COVID-19 patient severity and guiding treatment decisions.

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
266
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
350
Prediction Intervals01:03

Prediction Intervals

The interval estimate of any variable is known as the prediction interval. It helps decide if a point estimate is dependable.
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y. 
2.7K
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
1.2K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
526
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
720